Phase 1 study of KVD818 in healthy volunteers

Trial Profile

Phase 1 study of KVD818 in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs KVD 818 (Primary)
  • Indications Hereditary angioedema
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 01 Sep 2016 New trial record
    • 11 Aug 2016 According to KalVista media release, company announced the dosing of first patient in this trial.
    • 11 Aug 2016 According to KalVista media release, results from this study are expected to be announced in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top